Chinese Traditional and Herbal Drugs
|
2025, 56(9): 3354-3365
Research progress on Croci Stigma and its bioactive constituents for treatment of pulmonary diseases
Full
QIAN Yilei1, LI Chong1, WANG Yu1, LIN Shang1, MENG Qian1, LI Gen1, LI Jingxiang2, ZHANG Yimin1,3
Affiliations
1 Shandong University of Traditional Chinese Medicine, Jinan 250000, China;
2 The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250000, China;
3 Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine, Jinan 250000, China
doi: 10.7501/j.issn.0253-2670.2025.09.031
Outline
Under the combined effects of complex factors such as air pollution, occupational exposure, smoking, and passive smoking, the incidence of pulmonary diseases has been increasing annually. Conditions such as lung cancer, pulmonary fibrosis, and bronchial asthma have become major global public health challenges. Given the higher prevalence of these diseases among the elderly and their tendency to progress into chronic conditions, there is an urgent need for effective treatments with minimal adverse effects. Conventional chemical drugs, such as cephalosporin antibiotics, often lead to drug resistance and demonstrate limited therapeutic efficacy. Traditional Chinese medicine (TCM) has garnered increasing attention due to its multi-target, multi-pathway mechanisms and relatively high safety profile. Xihonghua (Croci Stigma) is known in TCM for its properties of cooling blood, detoxifying, promoting blood circulation, resolving stasis, and alleviating depression to calm the mind. Modern research has demonstrated that Croci Stigma exhibits various pharmacological activities, including antitumor, antiviral, anti-inflammatory, and antioxidative stress effects, with multiple mechanisms of action in prevention and treatment of pulmonary diseases. This review summarizes pharmacological effects of Croci Stigma and its bioactive constituents, as well as their mechanisms in managing pulmonary diseases, aiming to provide insights for future research and clinical applications.
Croci Stigma
/
respiratory disorders
/
terpenoids
/
phenolic acids
/
flavonoids
/
safranal
/
crocin
/
crocetin
钱艺蕾, 李冲, 王钰, 林尚, 孟倩, 李根, 李景祥, 张义敏.
西红花及其活性成分治疗肺系疾病的研究进展.
中草药,
2025
, 56
(9)
: 3354
-3365
.
DOI: 10.7501/j.issn.0253-2670.2025.09.031
QIAN Yilei, LI Chong, WANG Yu, LIN Shang, MENG Qian, LI Gen, LI Jingxiang, ZHANG Yimin.
Research progress on Croci Stigma and its bioactive constituents for treatment of pulmonary diseases[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(9)
: 3354
-3365
.
DOI: 10.7501/j.issn.0253-2670.2025.09.031
Year 2025 volume 56 Issue 9
47
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.09.031
- Receive Date:2025-01-17
- Online Date:2026-11-13